Cargando…

Allele-Specific Up-Regulation of FGFR2 Increases Susceptibility to Breast Cancer

The recent whole-genome scan for breast cancer has revealed the FGFR2 (fibroblast growth factor receptor 2) gene as a locus associated with a small, but highly significant, increase in the risk of developing breast cancer. Using fine-scale genetic mapping of the region, it has been possible to narro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meyer, Kerstin B, Maia, Ana-Teresa, O'Reilly, Martin, Teschendorff, Andrew E, Chin, Suet-Feung, Caldas, Carlos, Ponder, Bruce A. J
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2365982/ https://www.ncbi.nlm.nih.gov/pubmed/18462018 http://dx.doi.org/10.1371/journal.pbio.0060108

Ejemplares similares

Master regulators of FGFR2 signalling and breast cancer risk
por: Fletcher, Michael N. C., et al.
Publicado: (2013)

Extent of differential allelic expression of candidate breast cancer genes is similar in blood and breast
por: Maia, Ana-Teresa, et al.
Publicado: (2009)

TOX3 Mutations in Breast Cancer
por: Jones, James Owain, et al.
Publicado: (2013)

BaalChIP: Bayesian analysis of allele-specific transcription factor binding in cancer genomes
por: de Santiago, Ines, et al.
Publicado: (2017)

Calling Sample Mix-Ups in Cancer Population Studies
por: Lynch, Andy G., et al.
Publicado: (2012)

Allelic expression imbalance of PIK3CA mutations is frequent in breast cancer and prognostically significant
por: Correia, Lizelle, et al.
Publicado: (2022)

FGFR2 risk SNPs confer breast cancer risk by augmenting oestrogen responsiveness
por: Campbell, Thomas M., et al.
Publicado: (2016)

A Functional Variant at a Prostate Cancer Predisposition Locus at 8q24 Is Associated with PVT1 Expression
por: Meyer, Kerstin B., et al.
Publicado: (2011)

High-resolution array CGH clarifies events occurring on 8p in carcinogenesis
por: Cooke, Susanna L, et al.
Publicado: (2008)

Common germ-line polymorphism of C1QA and breast cancer survival
por: Azzato, E M, et al.
Publicado: (2010)

Genome-driven integrated classification of breast cancer validated in over 7,500 samples
por: Ali, H Raza, et al.
Publicado: (2014)

Intersect-then-combine approach: improving the performance of somatic variant calling in whole exome sequencing data using multiple aligners and callers
por: Callari, Maurizio, et al.
Publicado: (2017)

FGFR4 Arg388 allele correlates with tumour thickness and FGFR4 protein expression with survival of melanoma patients
por: Streit, S, et al.
Publicado: (2006)

MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype
por: Blenkiron, Cherie, et al.
Publicado: (2007)

A Prognostic Gene Signature for Metastasis-Free Survival of Triple Negative Breast Cancer Patients
por: Lee, UnJin, et al.
Publicado: (2013)

Transcriptional profiling reveals a subset of human breast tumors that retain wt TP53 but display mutant p53‐associated features
por: Benor, Gal, et al.
Publicado: (2020)

Differential oestrogen receptor binding is associated with clinical outcome in breast cancer
por: Ross-Innes, Caryn S., et al.
Publicado: (2012)

PMC42, a breast progenitor cancer cell line, has normal-like mRNA and microRNA transcriptomes
por: Git, Anna, et al.
Publicado: (2008)

The pitfalls of platform comparison: DNA copy number array technologies assessed
por: Curtis, Christina, et al.
Publicado: (2009)

Clues to the Function of the Tumour Susceptibility Gene BRCA2
por: Gayther, Simon A., et al.
Publicado: (1998)

Does massively parallel transcriptome analysis signify the end of cancer histopathology as we know it?
por: Aparicio, Samuel AJR, et al.
Publicado: (2000)

Allele-specific regulation of FGFR2 expression is cell type-dependent and may increase breast cancer risk through a paracrine stimulus involving FGF10
por: Huijts, Petra EA, et al.
Publicado: (2011)

Computational approach to discriminate human and mouse sequences in patient-derived tumour xenografts
por: Callari, Maurizio, et al.
Publicado: (2018)

Multiple sclerosis susceptibility alleles in African Americans
por: Johnson, Britt A., et al.
Publicado: (2009)

A robust classifier of high predictive value to identify good prognosis patients in ER-negative breast cancer
por: Teschendorff, Andrew E, et al.
Publicado: (2008)

The breast cancer somatic 'muta-ome': tackling the complexity
por: Teschendorff, Andrew E, et al.
Publicado: (2009)

Associations between genomic stratification of breast cancer and centrally reviewed tumour pathology in the METABRIC cohort
por: Mukherjee, A., et al.
Publicado: (2018)

WTF?: What's the Future and Why It's Up to Us
por: O'Reilly, Tim
Publicado: (2017)

The association of genetic variants in FGFR2 with osteoporosis susceptibility in Chinese Han population
por: Yang, Yang, et al.
Publicado: (2019)

The polymorphisms of FGFR2 and MGAT5 affect the susceptibility to COPD in the Chinese people
por: Li, Xiaobo, et al.
Publicado: (2021)

Risk Alleles for Multiple Myeloma Susceptibility in ADME Genes
por: Scionti, Francesca, et al.
Publicado: (2022)

Human and mouse oligonucleotide-based array CGH
por: van den IJssel, Paul, et al.
Publicado: (2005)

FGFR1 amplification or overexpression and hormonal resistance in luminal breast cancer: rationale for a triple blockade of ER, CDK4/6, and FGFR1
por: Mouron, Silvana, et al.
Publicado: (2021)

Lower mutant-allele tumor heterogeneity is a biomarker in FGFR3-mutant bladder cancer for better prognosis
por: Han, Yuying, et al.
Publicado: (2020)

The molecular landscape of Asian breast cancers reveals clinically relevant population-specific differences
por: Pan, Jia-Wern, et al.
Publicado: (2020)

Inflammasome lights up in systemic sclerosis
por: Henderson, John, et al.
Publicado: (2017)

Prognostic Value of MammaPrint(®) in Invasive Lobular Breast Cancer
por: Beumer, Inès J., et al.
Publicado: (2016)

Trumpet plots: visualizing the relationship between allele frequency and effect size in genetic association studies
por: Corte, Lucia, et al.
Publicado: (2023)

Growth charts in FGFR2- and FGFR3-related faciocraniosynostoses
por: Ea, Caroline, et al.
Publicado: (2022)

Resistance to Selective FGFR Inhibitors in FGFR-Driven Urothelial Cancer
por: Facchinetti, Francesco, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_uraanpv6k8qrj6mb00urn25ott